Drug Screening: Large-scale screening of compound libraries in cell models closer to the human environment to quickly discover effective candidate drugs.Toxicity Evaluation: Use iPSC-derived cardiomyocytes, hepatocytes, etc. for early cardiac and hepatic toxicity assessment, significantly improving the accuracy of drug safety prediction.What We Provide: Ready-to-use iPSC-derived functional cells (cardiac/liver/kidney cells), cardiac/liver organoid models, customized high-throughput drug screening and toxicity testing services.